Should I buy or sell CARGO Therapeutics stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CARGO Therapeutics in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CRGX shares. View CRGX analyst ratings or view top-rated stocks .

What is CARGO Therapeutics' stock price target for 2024?

4 equities research analysts have issued 1 year price objectives for CARGO Therapeutics' stock. Their CRGX share price targets range from $23.00 to $34.00. On average, they anticipate the company's share price to reach $28.33 in the next year. This suggests a possible upside of 22.4% from the stock's current price. View analysts price targets for CRGX or view top-rated stocks among Wall Street analysts .

How have CRGX shares performed in 2023?

CARGO Therapeutics' stock was trading at $14.53 at the beginning of the year. Since then, CRGX shares have increased by 59.3% and is now trading at $23.15. View the best growth stocks for 2023 here .

When is CARGO Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 13th 2024. View our CRGX earnings forecast .

When did CARGO Therapeutics IPO?

(CRGX) raised $281 million in an initial public offering (IPO) on Friday, November 10th 2023. The company issued 18,750,000 shares at a price of $15.00 per share.

When did CARGO Therapeutics' quiet period expire?

CARGO Therapeutics' quiet period expired on Wednesday, December 20th. CARGO Therapeutics had issued 18,750,000 shares in its initial public offering on November 10th. The total size of the offering was $281,250,000 based on an initial share price of $15.00. During CARGO Therapeutics' quiet period, insiders and any underwriters involved in the IPO were restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of CARGO Therapeutics?

Shares of CRGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CRGX

CARGO Therapeutics (CRGX) Stock Price, News & Analysis

$23.15

+0.43 (+1.89%)

(As of 12/29/2023 ET)

Compare

Today's Range: $21.65
▼
$29.01
50-Day Range: N/A
52-Week Range: $13.14
▼
$29.01

Volume: 462,614 shs
Average Volume: 204,063 shs
Market Capitalization: $954.01 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $28.33

Stock Analysis Analyst Forecasts Chart Competitors Financials Insider Trades SEC Filings Social Media

CARGO Therapeutics MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 22.4% Upside
$28.33 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.63
Based on 2 Articles This Week
Insider Trading: Acquiring Shares
$10 M Bought Last Quarter
Proj. Earnings Growth: Growing
From ($17.53) to ($5.85) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.62 out of 5 stars

Medical Sector

796th out of 950 stocks

Biological Products, Except Diagnostic Industry

140th out of 158 stocks

2.5

Analyst's Opinion

Consensus Rating
CARGO Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $28.33, CARGO Therapeutics has a forecasted upside of 22.4% from its current price of $23.15.
Amount of Analyst Coverage
CARGO Therapeutics has only been the subject of 4 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for CRGX.

0.0

Dividend Strength

Dividend Yield
CARGO Therapeutics does not currently pay a dividend.
Dividend Growth
CARGO Therapeutics does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CRGX.

2.6

News and Social Media Coverage

News Sentiment
CARGO Therapeutics has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for CARGO Therapeutics this week, compared to 3 articles on an average week.
Search Interest
3 people have searched for CRGX on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
MarketBeat Follows
5 people have added CARGO Therapeutics to their MarketBeat watchlist in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CARGO Therapeutics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $9,999,990.00 in company stock and sold $0.00 in company stock.

0.6

Earnings and Valuation

Earnings Growth
Earnings for CARGO Therapeutics are expected to grow in the coming year, from ($17.53) to ($5.85) per share.

See Top Rated MarketRank™ Stocks Here

About CARGO Therapeutics Stock (NASDAQ:CRGX)

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.

CRGX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CRGX Stock News Headlines

December 31, 2023 | americanbankingnews.com

CARGO Therapeutics (NASDAQ:CRGX) Stock Price Up 6.7%

December 24, 2023 | americanbankingnews.com

CARGO Therapeutics (NASDAQ:CRGX) Hits New 1-Year High at $21.80

December 31, 2023 | MarketBeat Internal (Ad)

New Year's Sale: Get MarketBeat All Access Free For 30 Days

Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscription

December 18, 2023 | bizjournals.com

Alexandria's San Carlos project lands Bay Area's latest biotech IPO company as big tenant

December 14, 2023 | finanznachrichten.de

Cargo Therapeutics, Inc.: CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results

December 13, 2023 | finance.yahoo.com

CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results

December 11, 2023 | wsj.com

CARGO Therapeutics Inc.

December 10, 2023 | benzinga.com

Cargo Therapeutics Stock (NASDAQ:CRGX) Insider Trades

December 31, 2023 | MarketBeat Internal (Ad)

New Year's Sale: Get MarketBeat All Access Free For 30 Days

December 7, 2023 | morningstar.com

Cargo Therapeutics Inc CRGX

December 6, 2023 | msn.com

Jefferies starts Cargo at buy, cites potential as M&A target

December 6, 2023 | finance.yahoo.com

CARGO Therapeutics Announces Scientific Advisory Board

December 5, 2023 | markets.businessinsider.com

Buy Rating Affirmed for CARGO Therapeutics on Strong CRG-022 Phase 1 Results and Market Potential

December 5, 2023 | uk.investing.com

CARGO Therapeutics Inc (CRGX)

See More Headlines

Receive CRGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CARGO Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 12/31/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/13/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:CRGX
Previous Symbol: NASDAQ:CRGX
CUSIP: N/A
CIK: 1966494
Web: cargo-tx.com
Phone: 650-379-6143
Fax: N/A
Employees: 42
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $28.33
High Stock Price Target: $34.00
Low Stock Price Target: $23.00
Potential Upside/Downside: +22.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 41,210,000
Free Float: N/A
Market Cap: $954.01 million
Optionable: N/A
Beta: N/A

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Ms. Gina Chapman (Age 56)
President, CEO & Director
Comp: $755.35k
Dr. Crystal L. Mackall M.D. (Age 63)
Co-Founder
Comp: $160k
Dr. Shishir Gadam Ph.D. (Age 56)
Chief Technical Officer
Comp: $674.03k
Dr. Robbie Majzner M.D.
Founder & Chair of Scientific Advisory Board
Ms. Nancy Goodman J.D.
Founder
Dr. Louai Labanieh
Founder
Mr. Anup Radhakrishnan (Age 44)
CFO, Secretary & Chief Business Officer
Dr. Corinne D. Epperly M.D. (Age 45)
M.P.H., Chief Operating Officer
Mr. Faisal Shawwa M.B.A.
Senior Vice President of Finance & Accounting
Dr. Michael Ports Ph.D. (Age 42)
Chief Scientific Officer

Key Competitors

View All Competitors

Insiders

Perceptive Advisors Llc
Bought 666,666 shares on 11/14/2023
Total: $10.00 M ($15.00/share)

View All Insider Transactions

CRGX Stock Analysis - Frequently Asked Questions

Should I buy or sell CARGO Therapeutics stock right now?: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CARGO Therapeutics in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CRGX shares.
View CRGX analyst ratings or view top-rated stocks.
What is CARGO Therapeutics' stock price target for 2024?: 4 equities research analysts have issued 1 year price objectives for CARGO Therapeutics' stock. Their CRGX share price targets range from $23.00 to $34.00. On average, they anticipate the company's share price to reach $28.33 in the next year. This suggests a possible upside of 22.4% from the stock's current price.
View analysts price targets for CRGX or view top-rated stocks among Wall Street analysts.
How have CRGX shares performed in 2023?: CARGO Therapeutics' stock was trading at $14.53 at the beginning of the year. Since then, CRGX shares have increased by 59.3% and is now trading at $23.15.
View the best growth stocks for 2023 here.
When is CARGO Therapeutics' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 13th 2024.
View our CRGX earnings forecast.

When did CARGO Therapeutics IPO?: (CRGX) raised $281 million in an initial public offering (IPO) on Friday, November 10th 2023. The company issued 18,750,000 shares at a price of $15.00 per share.
When did CARGO Therapeutics' quiet period expire?: CARGO Therapeutics' quiet period expired on Wednesday, December 20th. CARGO Therapeutics had issued 18,750,000 shares in its initial public offering on November 10th. The total size of the offering was $281,250,000 based on an initial share price of $15.00. During CARGO Therapeutics' quiet period, insiders and any underwriters involved in the IPO were restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.
How do I buy shares of CARGO Therapeutics?: Shares of CRGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CRGX) was last updated on 12/31/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CARGO Therapeutics (CRGX) Stock Price, News & Analysis

CARGO Therapeutics MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Consensus Rating

Price Target Upside/Downside

Amount of Analyst Coverage

Short Interest

Short Interest

Dividend Strength

Dividend Yield

Dividend Growth

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Insider Buying vs. Insider Selling

Earnings and Valuation

Earnings Growth

About CARGO Therapeutics Stock (NASDAQ:CRGX)

CRGX Stock Price History

CRGX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

CRGX Stock Analysis - Frequently Asked Questions

Overall MarketRank^™